ERBB2 and breast cancer: In aggressive high-grade tumors as HER2-positive metastatic BC, it has been shown that CB2R is overexpressed, and treatment with Δ9-THC, THC 14 and selective agonists for CB2R has shown great potential [155,156,166,167].